Schedule 13D ownership disclosure

Taysha Gene Therapies Inc

Security class unavailable · CUSIP: 877619106

Event date: 2023-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-216942
Form type
SC 13D/A
Filer
Manning Paul B
CIK
CIK 1494695
Filed
Aug 21, 2023
Reporting period
Aug 16, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub